GE Healthcare is joining with imaging services firm RadNet to pilot GE's Best Pathways initiative, a breast cancer detection optimization model.
GE Healthcare and RadNet will evaluate the clinical breast cancer detection process, identifying inefficient diagnostic patterns and ways to lower cost and improve patient outcomes. The program will focus on subpopulations of women in which guidelines are lacking and substantial variability is observed in clinical practice, according to GE.
The Best Pathways initiative was developed in collaboration with academic and community mammographers, primary care physicians, and breast surgeons to explore alternative detection strategies and understand the need for new diagnostic technologies, GE said.
